21 CFR 520.2340

§ 520.2340 Tepoxalin.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 520.2340, § 520.2340 Tepoxalin, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87342
Permanent ID: ys:prov:87342@1
SHA-256: c3d4f002530cfb4fdae8be8cb7823f51cda9ba5715496f13e73feb5ec0d6f644

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each tablet contains 30, 50, 100, or 200 milligrams (mg) tepoxalin. (b) Sponsor. See No. 000061 in § 510.600(c) of this chapter. (c) Conditions of use in dogs—(1) Amount. 10 mg per kilogram (/kg) daily; or 20 mg/kg on the initial day of treatment, followed by 10 mg/kg daily. (2) Indications for use. For the control of pain and inflammation associated with osteoarthritis. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.